check my old posts about alinia and DNA-BASED AMPHIPATHIC POLYMER/rapid HBsAg SEROCONVERSION
the solution will come out slowly and for big pharma the best solution is an ativiral tx for life like on hiv
i think the solution is close because all trials on new
hiv/hbv antivirals have stopped on hbv on
2009 but only for hbv not hiv, also alinia on hbv seams to have been stopped
it also looks very odd that there is an incredible number of trials on hcv now which is a small market compared to hbv